-
China Covid Row: India to Review the Situation 2022-12-21 07:55:19
China is back with the scare of coronavirus and the new cases have seen a huge rise all over. With the neighboring nation reporting huge number of cases, the Indian government is all set to review the situation. A total...
Keywords: China Covid Row India, China Covid Row cases, China Covid Row cases, China Covid Row cases
Read More
Latest Coronavirus Variant Evades Vaccine Protection 2021-08-31 09:12:09
The new variants of coronavirus continue to emerge when the whole world is battling to prevent the spread of the deadly virus. A new variant is now detected in South Africa and it is known to be more transmissible and...
Keywords: new covid variant, C.1.2 variant in South Africa, C.1.2 variant updates, C.1.2 variant updates
Read More
First Case of Omicron BQ.1 Sub-Variant Found in India 2022-10-18 13:23:26
India reported its first case of BQ.1, the sub-variant of Omicron in Pune. The case was found in a sample in Pune. It is a descendant of BA.5 of Omicron which is a dominant version of SARS-CoV-2 in the USA....
Keywords: Omicron, Omicron BQ.1 sub-variant breaking news, Omicron BQ.1 sub-variant India, Omicron BQ.1 sub-variant Pune
Read More
All you need to know about the new Delta plus variant of Coronavirus 2021-06-15 09:56:12
The Delta variant which is called SARS-CoV-2 has now mutated further into Delta plus or the AY.1 variant. The delta variant was first identified in India. As per Public Health England, 63 genomes of Delta (B.1.617.2) with the new K417N...
Keywords: Delta plus latest, Delta plus Coronavirus, Delta plus breaking news, Delta plus new updates
Read More
Bharat Biotech to begin Phase 3 Trials of Covaxin in UP from October 2020-09-25 14:45:44
The UP government on Thursday announced the Phase 3 trials of Covaxin, Bharat Biotech’s COVID-19 vaccine that will start in Lucknow and Gorakhpur. Bharat Biotech’s Covaxin, the COVID-19 vaccine developed indigenously has reached the phase 3 trials with the announcement...
Keywords: Phase 3 trials, Phase 3 trials, Phase 3 trials, Bharat Biotech
Read More
Everything about FELUDA, a low-cost COVID-19 Test in India 2020-09-21 16:01:23
Developed by CSIR, the device uses genome-editing technology and gives similar results to the RT-PCR test. The Drug Controller General of India (DCGI) has approved the commercial launch of FELUDA, which is a low-cost COVID test developed by the Tata...
Keywords: genome, technology, CSIR, FELUDA test
Read More
Edition:
